UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)

UTSW 神经科学临床试验卓越网络临床研究网站 (NeuroNEXT)

• 批准号: 9571862
• 负责人: Mark Paul Goldberg
• 金额: $ 32.4万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-07-15 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9571862
• 关键词: Adult; African American; Area; Brain; Caring; Catchment Area; Center for Translational Science Activities; Child; Clinical; Clinical Research; Clinical Trials; Clinical and Translational Science Awards; Clinics and Hospitals; Collaborations; Communities; Community Outreach; Data Quality; Databases; Development; Disease; Educational Curriculum; Enrollment; Ensure; Equipment; Expenditure; Faculty; Funding; Future; Goals; Health; Health Resources; Health system; Hispanic Americans; Hospitals; Human Resources; Institutes; Institution; Integrated Health Care Systems; Leadership; Medical center; Mentorship; Nervous system structure; Neurology; Neurosciences; Neurosciences Research; Patient Recruitments; Patients; Pediatric Hospitals; Pediatric Neurology; Pediatrics; Performance; Population; Population Heterogeneity; Process; Psychiatry; Publications; Rehabilitation therapy; Research; Research Infrastructure; Research Personnel; Research Support; Research Training; Resources; Services; Site; Speed; Structure; Talents; Texas; Time; Training; Training Programs; Training Support; Translating; United States; United States National Institutes of Health; Universities; University Hospitals; academic program; career development; clinical data warehouse; clinical research site; collaborative environment; data warehouse; expectation; experience; improved; innovation; medical specialties; member; metropolitan; multidisciplinary; nervous system disorder; neurosurgery; operation; professor; programs; recruit; screening; success; tool; translational medicine; translational neuroscience

This is an application for competitive renewal of UT Southwestern Medical Center (UTSW) as a clinical research site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT). The project continues to be led by Drs. Mark Goldberg and Susan Iannaccone, who bring experience in program leadership with complementary areas of expertise in adult and pediatric neurology, respectively. The project has demonstrated enrollment and operational successes in the initial funding period. UTSW is one of the few sites selected to participate in all eight funded studies by the network (NN109 site selection is still underway). We are among the top five enrolling sites and have met or exceeded network averages for patient recruitment, retention, timeliness, data quality and accuracy metrics. We propose to expand on these successes in the next cycle. First, we will take advantage of new institutional relationships to expand the number of patients available for screening and enrollment. UTSW has partnered with a large health network, Texas Health Resources, to create an integrated health system of 31 hospitals and clinics called the Southwestern Health Resources (SWHR). Altogether, our collaborative research relationships with community care partners and health systems brings potential enrollment access to almost three quarters of the Dallas-Fort Worth metroplex. In addition, the newly formed Peter O’Donnell Jr. Brain Institute at UTSW brings together several departments and centers focused on the study of the nervous system under a multi-disciplinary, collaborative umbrella. Second, we will make use of innovative research resources to improve the speed, efficiency, and quality of clinical trials. With the initial launch of NeuroNEXT, we established the Neuroscience Translational Research Center (NTRC), which provides core services, dedicated research space, equipment, regulatory expertise, and trained personnel for NIH and other studies across the clinical neurosciences. This resource has grown in scope and quality, and will be further enhanced with improved database support, an expanded institutional EMR-to-research data warehouse, and new online tools for patient recruitment and enrolment. Third, we will implement a clinical research curriculum, taking advantage of existing resources for early stage investigators (ESI) in collaboration with the Center for Translational Medicine (CTM) at UTSW. We have had ESIs serve as study PIs on six of the eight NeuroNEXT studies, proving our commitment to early career development. We will continue provide structured curriculum with clinical research mentorship to several candidates from our talented pool of ESIs.

这是UT西南医学中心（UTSW）作为神经科学临床试验卓越网络（NeuroNEXT）临床研究站点的竞争性更新申请。该项目继续由dr。Mark Goldberg和Susan Iannaccone，他们分别在成人和儿童神经病学领域带来了项目领导经验和互补的专业知识。该项目在最初的资助期内取得了招生和运营上的成功。西南科技大学是为数不多的被选中参与所有8项由该网络资助的研究的地点之一（NN109的选址仍在进行中）。我们是前五大注册网站之一，在患者招募、保留、及时性、数据质量和准确性指标方面达到或超过了网络平均水平。我们建议在下一个周期中扩大这些成功。首先，我们将利用新的机构关系来扩大可用于筛查和登记的患者数量。UTSW与一个大型健康网络德克萨斯健康资源合作，创建了一个由31家医院和诊所组成的综合健康系统，称为西南健康资源（SWHR）。总之，我们与社区护理合作伙伴和卫生系统的合作研究关系为达拉斯-沃斯堡大都会区近四分之三的地区带来了潜在的入学机会。此外，新南威尔士大学新成立的小彼得·奥唐纳脑研究所（Peter O 'Donnell Jr. Brain Institute）将几个专注于神经系统研究的部门和中心聚集在一个多学科合作的伞下。二是利用创新科研资源，提高临床试验速度、效率和质量。随着NeuroNEXT的初步启动，我们建立了神经科学转化研究中心（NTRC），为NIH和其他临床神经科学研究提供核心服务、专用研究空间、设备、监管专业知识和训练有素的人员。这一资源的范围和质量都有所增加，并将通过改进数据库支持、扩大机构从电子病历到研究的数据仓库以及用于患者招募和登记的新在线工具进一步得到加强。第三，我们将与悉尼大学转化医学中心（CTM）合作，利用现有的早期研究人员（ESI）资源，实施临床研究课程。在8项NeuroNEXT研究中，有6项是我们的ei作为研究pi，证明了我们对早期职业发展的承诺。我们将继续提供结构化的课程和临床研究指导，从我们的人才池中选出几位候选人。